NCT04218422 Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
| NCT ID | NCT04218422 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wayne State University |
| Condition | Hidradenitis Suppurativa |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2020-01-22 |
| Primary Completion | 2030-12-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 32 participants in total. It began in 2020-01-22 with a primary completion date of 2030-12-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.
Eligibility Criteria
Inclusion Criteria: * age 18 years or older * dermatologist-confirmed diagnosis of hidradenitis suppurativa * significant pain from hidradenitis at least twice weekly * stable treatment regimen for hidradenitis during study period Exclusion Criteria: * disease or disfigurement of the ear that prevents battlefield acupuncture of the ears * other chronic pain that will interfere with the ability to rate hidradenitis pain
Frequently Asked Questions
Who can join the NCT04218422 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hidradenitis Suppurativa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04218422 currently recruiting?
Yes, NCT04218422 is actively recruiting participants. Visit ClinicalTrials.gov or contact Wayne State University to inquire about joining.
Where is the NCT04218422 trial being conducted?
This trial is being conducted at Dearborn, United States.
Who is sponsoring the NCT04218422 clinical trial?
NCT04218422 is sponsored by Wayne State University. The trial plans to enroll 32 participants.